Dabigatran anticoagulation and Stanford type A aortic dissection: Lethal coincidence: Case report with literature review

18Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background Novel oral anticoagulants are now encountered in patients needing emergency surgery. Knowledge and treatment options are limited. Methods and result We present the case of a 76-year-old patient who suffered from an acute Stanford type A aortic dissection, needing emergency surgical aortic repair. He was anticoagulated with dabigatran due to past atrial fibrillation. Despite haemodiafiltration, surgical revision and massive transfusion of packed red blood cells, fresh frozen plasma, platelets, coagulation factors, and recombinant factor VIIa, the patient died from intractable bleeding with sustained therapeutic levels of dabigatran. Conclusion After reviewing the literature, we summarize the limited treatment options and show possible approaches for patients treated with dabigatran needing emergency surgery. © 2014 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Cite

CITATION STYLE

APA

Stein, P., Bosshart, M., Brand, B., Schlicker, A., Spahn, D. R., & Bettex, D. (2014). Dabigatran anticoagulation and Stanford type A aortic dissection: Lethal coincidence: Case report with literature review. Acta Anaesthesiologica Scandinavica. Blackwell Munksgaard. https://doi.org/10.1111/aas.12303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free